• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

REMICADE

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Hepatitis and Autoimmune Diseases Drugs

August 24, 2018Autoimmune Diseases, Hepatitis, Vizit Graphs
Hepatitis and Autoimmune Diseases Drugs

Managing infections and autoimmunity with Remicade and Ribavirin. Explore the live graph.

Vizit Graphs Tag Cloud

CLOSTRIDIUM DIFFICILE IL6 APOPTOTIC PROCESS IFNG AUTOPHAGY CELL PROLIFERATION TP53 PORPHYROMONAS GINGIVALIS CELL DEATH STAPHYLOCOCCUS AUREUS METFORMIN AGING CANCER CANDIDA ALBICANS CD4 PARKINSON DISEASE INFLAMMATION IL23A IL17A RHEUMATOID ARTHRITIS TNF ERBB-2 DOXORUBICIN CASP3 FOXP3 RECEPTOR ALZHEIMER'S DISEASE LISTERIA MONOCYTOGENES CELL DIVISION PSEUDOMONAS AERUGINOSA INSULIN TH17 CELLS DIABETES MELLITUS REMICADE ESCHERICHIA COLI CELL DIFFERENTIATION NEURODEGENERATIVE DISORDERS SOD1 BREAST CANCER ANGIOGENESIS STREPTOCOCCUS PNEUMONIAE IMMUNE RESPONSE CTLA4 HELICOBACTER PYLORI 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE

© 2019 Biovista Vizit All Rights Reserved.